Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18
Orders ship US-compounded material with a per-lot certificate of analysis
BMJ Open 10 , e035108 (2020)
Pharmacokinetic studies on IDB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects
| Risk Dimension | Evidence Quality | Severity if Realized | Practical Impact | |---|---|---|---| | Absorption interference (oral, same-time dosing) | Indirect/mechanistic | Moderate (reduced efficacy) | High: fixable with timing | | Direct chelation (glutathione binds alendronate) | None documented | Low | Low | | Pharmacodynamic antagonism (bone) | None documented | Potentially none or positive | Low | | Hepatic CYP interaction | Not applicable | None | None | | Renal clearance competition (IV glutathione) | Theoretical only | Unknown | Moderate precaution warranted | The dominant clinical concern is absorption interference, and it is entirely preventable with correct timing
Vitamin C, supports for immune function, collagen synthesis, and overall wellness
Routine-Friendly: Our GHK-Cu + AHK-Cu peptide serum fits naturally into AM/PM habits and offers an easy way to use peptides serum as part of a cosmetic personal care routine
